Navigation Links
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Date:9/27/2007

CLARITY and COMMIT trials."

The 300mg tablet is bioequivalent to four 75mg FDA approved tablets of PLAVIX. The 300mg tablet of clopidogrel will be available in the U.S. later this year and is also currently under European Medicines Evaluation Agency (EMEA) review.

About PLAVIX

PLAVIX is a prescription antiplatelet medicine taken once a day that helps keep platelets in the blood from sticking together and forming clots. Since its initial approval on November 17, 1997, by the U.S. Food and Drug Administration, PLAVIX has been prescribed to more than 52 million patients worldwide. The new 300mg loading dose tablet reinforces the strong commitment of two research and development pharmaceutical companies dedicated to improving patient health.

The efficacy and safety of PLAVIX have been established through four landmark clinical trials involving more than 81,000 patients. Plavix is the only widely available prescription antiplatelet that provides proven protection against a future heart attack or stroke for patients with ACS (UA, NSTEMI, STEMI) and recent MI, recent Stroke, or established peripheral artery disease.

PLAVIX has demonstrated early and long-term risk reduction for patients at risk for atherothrombotic events in important clinical trials. In the CURE trial, patients with unstable angina (UA) and non-ST segment elevation myocardial infarction (NSTEMI) receiving PLAVIX with aspirin were followed for up to one year, and in the CAPRIE trial, patients with recent MI, recent ischemic stroke, or established peripheral artery disease receiving PLAVIX alone were followed for up to three years.

PLAVIX is marketed worldwide by sanofi-aventis (Paris Bourse: EURONEXT: SAN; New York: NYSE: SNY) and Bristol-Myers Squibb Company (NYSE:

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. UW Board of Regents approves $134 million medical research facility
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Integration of the LEADseeker Multimodality Imaging System with automated plate loading and incubation using Overlord Instrument software
9. Marquette targets illegal downloading
10. Though VC investing is down, reloading on new funds is rising
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):ESHRE announces its campus workshop: 'Artificial Insemination: An Update' 2Abundance of a look-alike species clouds population status of a million dollar fish 2Abundance of a look-alike species clouds population status of a million dollar fish 3Charles Darwin: More than the origin 2Charles Darwin: More than the origin 3Physicians Practice and Pocono Medical Center to Improve Patient Care in Monroe County Pennsylvania 48440 1Physicians Practice and Pocono Medical Center to Improve Patient Care in Monroe County Pennsylvania 48440 2Physicians Practice and Pocono Medical Center to Improve Patient Care in Monroe County Pennsylvania 48440 3Physicians Practice and Pocono Medical Center to Improve Patient Care in Monroe County Pennsylvania 48440 4American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 1American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 2American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 4Summer Travel Destinations are Heavy on Fun and Sun 48434 1Summer Travel Destinations are Heavy on Fun and Sun 48434 2Summer Travel Destinations are Heavy on Fun and Sun 48434 3